Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 161 articles:
HTML format

Single Articles

    January 2024
  1. EVANS SM, Ivanova K, Cossio D, Pilgrim CHC, et al
    Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia.
    PLoS One. 2024;19:e0294443.
    PubMed     Abstract available

  2. SECHRIST ZR, Lee G, Schwarz EM, Cole CL, et al
    Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0292196.
    PubMed     Abstract available

  3. HUANG H, Huang Z, Chen M, Okamoto K, et al
    Evaluation of the therapeutic efficiency and efficacy of blood purification in the treatment of severe acute pancreatitis.
    PLoS One. 2024;19:e0296641.
    PubMed     Abstract available

  4. KHRISTENKO E, Sinitsyn V, Rieden T, Girod P, et al
    CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    PLoS One. 2024;19:e0291185.
    PubMed     Abstract available

  5. Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer.
    PLoS One. 2024;19:e0298197.

  6. KORDSHOULI SO, Tahmasebi A, Moghadam A, Ramezani A, et al
    A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0289561.
    PubMed     Abstract available

  7. Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.
    PLoS One. 2024;19:e0298557.

  8. TUSHOSKI-ALEMAN GW, Herremans KM, Underwood PW, Akki A, et al
    Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
    PLoS One. 2024;19:e0297325.
    PubMed     Abstract available

  9. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
    Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    PLoS One. 2024;19:e0294049.
    PubMed     Abstract available

  10. HUAN L, Yu F, Cao D, Zhou H, et al
    Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0295983.
    PubMed     Abstract available

  11. GRIFFIN JI, Chen X, Duan L, Mu Q, et al
    Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
    PLoS One. 2024;19:e0300723.
    PubMed     Abstract available

  12. LANG H, Lin N, Chen X, Xiang J, et al
    Repressing miR-23a promotes the transdifferentiation of pancreatic alpha cells to beta cells via negatively regulating the expression of SDF-1alpha.
    PLoS One. 2024;19:e0299821.
    PubMed     Abstract available

  13. ZHANG C, Lin F, Guo DF, Wang QL, et al
    Assessing the causal link between liver function and acute pancreatitis: A Mendelian randomisation study.
    PLoS One. 2024;19:e0300890.
    PubMed     Abstract available

  14. MEHRA T, Lupatsch JE, Kossler T, Dedes K, et al
    Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0301271.
    PubMed     Abstract available

  15. HAWKINS HJ, Yacob BW, Brown ME, Goldstein BR, et al
    Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
    PLoS One. 2024;19:e0298808.
    PubMed     Abstract available

  16. SASAKI Y, Inouchi T, Nakatsuka R, Inoue A, et al
    Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells.
    PLoS One. 2024;19:e0302130.
    PubMed     Abstract available

  17. SHEN X, Zhu X, Liu H, Yuan R, et al
    Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.
    PLoS One. 2024;19:e0302361.
    PubMed     Abstract available

  18. DUTTA D, Ray P, De A, Ghosh A, et al
    pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
    PLoS One. 2024;19:e0297749.
    PubMed     Abstract available

  19. ZHU J, Wu L, Wang Y, Fang M, et al
    Predictive value of the Ranson and BISAP scoring systems for the severity and prognosis of acute pancreatitis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302046.
    PubMed     Abstract available

  20. KIM MC, Kim JH, Jeon SK, Kang HJ, et al
    CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    PLoS One. 2024;19:e0298278.
    PubMed     Abstract available

  21. HUANG K, Yuan X, Zhao P, He Y, et al
    Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: A large real-world study based on machine learning.
    PLoS One. 2024;19:e0302685.
    PubMed     Abstract available

    January 2023
  22. IKEZAWA K, Tanaka S, Fukuda J, Nakao M, et al
    Main pancreatic duct dilatation and pancreatic cysts in relatives and spouses of patients with pancreatic cancer.
    PLoS One. 2023;18:e0280403.
    PubMed     Abstract available

  23. HA CSR, Muller-Nurasyid M, Petrera A, Hauck SM, et al
    Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning.
    PLoS One. 2023;18:e0280399.
    PubMed     Abstract available

  24. ACHTERBERG FB, Mulder BGS, Janssen QP, Koerkamp BG, et al
    Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study.
    PLoS One. 2023;18:e0280939.
    PubMed     Abstract available

  25. SHAREF AY, Hamdi BA, Alrawi RA, Ahmad HO, et al
    Onopordum acanthium L. extract attenuates pancreatic beta-Cells and cardiac inflammation in streptozocin-induced diabetic rats.
    PLoS One. 2023;18:e0280464.
    PubMed     Abstract available

  26. OBONYO D, Uslar VN, Munding J, Weyhe D, et al
    The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis.
    PLoS One. 2023;18:e0281921.
    PubMed     Abstract available

  27. BIEL TG, Petrovskaya S, Mascia F, Ju T, et al
    Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients.
    PLoS One. 2023;18:e0281182.
    PubMed     Abstract available

  28. TIAN W, Zhang L, Liu X, Ma X, et al
    Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0282360.
    PubMed     Abstract available

  29. LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
    Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
    PLoS One. 2023;18:e0281979.
    PubMed     Abstract available

  30. BASNET S, Ghimire MP, Lamichhane TR, Adhikari R, et al
    Identification of potential human pancreatic alpha-amylase inhibitors from natural products by molecular docking, MM/GBSA calculations, MD simulations, and ADMET analysis.
    PLoS One. 2023;18:e0275765.
    PubMed     Abstract available

  31. WANG L, Luo P, Yang Z, Zhong X, et al
    FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.
    PLoS One. 2023;18:e0280794.
    PubMed     Abstract available

  32. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    PubMed     Abstract available

  33. CHEN Q, Lin J, Chen Z, Che L, et al
    Circular RNA expression alterations and function prediction in OSA-induced pancreatic injury in mice: New insights into pathogenesis.
    PLoS One. 2023;18:e0284459.
    PubMed     Abstract available

  34. HENG X, Chen B, Zhao K, Li J, et al
    Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
    PLoS One. 2023;18:e0284930.
    PubMed     Abstract available

  35. SHIM JY, Chung JO, Jung D, Kang PS, et al
    Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic beta cells.
    PLoS One. 2023;18:e0281496.
    PubMed     Abstract available

  36. XIAO X, Wu X, Fu Q, Ren X, et al
    Efficacy and safety of Dachaihu Decoction for acute pancreatitis: Protocol for a systematic review and meta-analysis.
    PLoS One. 2023;18:e0285661.
    PubMed     Abstract available

  37. DIKE CR, Sun QK, Rahib L, Golden M, et al
    Extra-pancreatic manifestations reported in association with pancreatitis; an international survey report.
    PLoS One. 2023;18:e0288337.
    PubMed     Abstract available

  38. AMINI M, Azizmohammad Looha M, Rahimi Pordanjani S, Asadzadeh Aghdaei H, et al
    Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease study 2019 data.
    PLoS One. 2023;18:e0288755.
    PubMed     Abstract available

  39. LING R, Liang J, Mo S, Qi J, et al
    Physical activity, sedentary behavior and pancreatitis risk: Mendelian randomization study.
    PLoS One. 2023;18:e0287810.
    PubMed     Abstract available

  40. SHIMAGAKI T, Sugimachi K, Mano Y, Tomino T, et al
    A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
    PLoS One. 2023;18:e0288033.
    PubMed     Abstract available

  41. HEINZMAN C, Hornung L, Lin TK, Lowe CMO, et al
    Total pancreatectomy with islet autotransplantation reduces opioid use and improves nutritional support in children with debilitating pancreatitis.
    PLoS One. 2023;18:e0289620.
    PubMed     Abstract available

  42. KAUR G, Helmer RA, Martinez-Marin D, Sennoune SR, et al
    Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic beta cells resulting in neonatal lethality.
    PLoS One. 2023;18:e0286109.
    PubMed     Abstract available

  43. ZHANG Y, Kirk CA, Tolbert MK, Steiner JM, et al
    Impact of fatty acid composition on markers of exocrine pancreatic stimulation in dogs.
    PLoS One. 2023;18:e0290555.
    PubMed     Abstract available

  44. LIU S, Li H, Xue Y, Yang L, et al
    Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0290888.
    PubMed     Abstract available

  45. LAPIN M, Tjensvoll K, Nedrebo K, Taksdal E, et al
    Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.
    PLoS One. 2023;18:e0291623.
    PubMed     Abstract available

  46. JANTHONGKAW A, Klaophimai S, Khampaya T, Yimthiang S, et al
    Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.
    PLoS One. 2023;18:e0291738.
    PubMed     Abstract available

  47. Ex pression of Concern: Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0292422.

  48. AZEVEDO-POULY A, Hale MA, Swift GH, Hoang CQ, et al
    Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation.
    PLoS One. 2023;18:e0291512.
    PubMed     Abstract available

  49. BRAYER KJ, Hanson JA, Cingam S, Martinez C, et al
    The inflammatory response of human pancreatic cancer samples compared to normal controls.
    PLoS One. 2023;18:e0284232.
    PubMed     Abstract available

  50. INGLE K, LaComb JF, Graves LM, Baines AT, et al
    AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
    PLoS One. 2023;18:e0294065.
    PubMed     Abstract available

  51. Retraction: Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer.
    PLoS One. 2023;18:e0294385.

    CT scan pancreatic cancer segmentation and classification using deep learning and the tunicate swarm algorithm.
    PLoS One. 2023;18:e0292785.
    PubMed     Abstract available

  53. Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0294622.

  54. DAILEY KM, Small JM, Pullan JE, Winfree S, et al
    An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
    PLoS One. 2023;18:e0289183.
    PubMed     Abstract available

  55. KARBHARI A, Mosessian S, Trivedi KH, Valla F Jr, et al
    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
    PLoS One. 2023;18:e0294564.
    PubMed     Abstract available

  56. KANAPARTHY NS, Loza AJ, Hauser RG
    Crawling toward obsolescence: The extended lifespan of amylase for pancreatitis.
    PLoS One. 2023;18:e0296180.
    PubMed     Abstract available

    January 2022
  57. KRUGER D, Lahoud N, Yako YY, Devar J, et al
    Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease.
    PLoS One. 2022;17:e0262439.
    PubMed     Abstract available

  58. ALVES FAV, Oliveira LLS, Salomao NG, Provance DW Jr, et al
    Cytokines and inflammatory mediators: Markers involved in interstitial damage to the pancreas in two dengue fever cases associated with acute pancreatitis.
    PLoS One. 2022;17:e0262785.
    PubMed     Abstract available

  59. KARKI B, Thapa S, Khadka D, Karki S, et al
    Intravenous Ringers lactate versus normal saline for predominantly mild acute pancreatitis in a Nepalese Tertiary Hospital.
    PLoS One. 2022;17:e0263221.
    PubMed     Abstract available

  60. Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2022;17:e0263037.

  61. MUHAMMADZAI J, Haider K, Moser M, Chalchal H, et al
    Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study.
    PLoS One. 2022;17:e0263250.
    PubMed     Abstract available

  62. RYDENFELT K, Strand-Amundsen R, Horneland R, Hodnebo S, et al
    Microdialysis and CO2 sensors detect pancreatic ischemia in a porcine model.
    PLoS One. 2022;17:e0262848.
    PubMed     Abstract available

  63. LUIKEN I, Eisenmann S, Garbe J, Sternby H, et al
    Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severity.
    PLoS One. 2022;17:e0263739.
    PubMed     Abstract available

  64. VITALE DS, Lahni P, Hornung L, Thompson T, et al
    Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis.
    PLoS One. 2022;17:e0261708.
    PubMed     Abstract available

  65. YAMAI T, Ikezawa K, Hiraga E, Kawamoto Y, et al
    Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
    PLoS One. 2022;17:e0264653.
    PubMed     Abstract available

  66. TANIUCHI K, Ueno M, Yokose T, Sakaguchi M, et al
    Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients.
    PLoS One. 2022;17:e0265172.
    PubMed     Abstract available

  67. GARDNER KP, Tsai S, Aldakkak M, Gironda S, et al
    CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.
    PLoS One. 2022;17:e0264763.
    PubMed     Abstract available

  68. STHIJNS MMJPE, Rademakers T, Oosterveer J, Geuens T, et al
    The response of three-dimensional pancreatic alpha and beta cell co-cultures to oxidative stress.
    PLoS One. 2022;17:e0257578.
    PubMed     Abstract available

  69. DONG Y, Ruano SH, Mishra A, Pennington KA, et al
    Adrenomedullin and its receptors are expressed in mouse pancreatic beta-cells and suppresses insulin synthesis and secretion.
    PLoS One. 2022;17:e0265890.
    PubMed     Abstract available

  70. ARNOLETTI JP, Reza J, Rosales A, Monreal A, et al
    Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    PLoS One. 2022;17:e0265725.
    PubMed     Abstract available

  71. MURATA Y, Ogura T, Hayasaki A, Gyoten K, et al
    Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy.
    PLoS One. 2022;17:e0264573.
    PubMed     Abstract available

  72. KUMSTEL S, Schreiber T, Goldstein L, Stenzel J, et al
    Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
    PLoS One. 2022;17:e0266601.
    PubMed     Abstract available

  73. UWAGAWA T, Sakamoto T, Gocho T, Shiba H, et al
    Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
    PLoS One. 2022;17:e0267623.
    PubMed     Abstract available

  74. NURMI AM, Hagstrom J, Mustonen H, Seppanen H, et al
    The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
    PLoS One. 2022;17:e0267792.
    PubMed     Abstract available

  75. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    PubMed     Abstract available

  76. YAMAKAWA K, Koyanagi-Aoi M, Uehara K, Masuda A, et al
    Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
    PLoS One. 2022;17:e0266620.
    PubMed     Abstract available

  77. THEGE FI, Cardle II, Gruber CN, Siemann MJ, et al
    Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids.
    PLoS One. 2022;17:e0267882.
    PubMed     Abstract available

  78. IWATATE Y, Yokota H, Hoshino I, Ishige F, et al
    Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer.
    PLoS One. 2022;17:e0268630.
    PubMed     Abstract available

  79. KASSAY N, Toldi V, Tozser J, Szabo A, et al
    Cigarette smoke toxin hydroquinone and misfolding pancreatic lipase variant cooperatively promote endoplasmic reticulum stress and cell death.
    PLoS One. 2022;17:e0269936.
    PubMed     Abstract available

  80. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    PubMed     Abstract available

  81. SAKAMOTO T, Makinoya M, Sunaguchi T, Goto K, et al
    Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer.
    PLoS One. 2022;17:e0271073.
    PubMed     Abstract available

  82. HARPER MM, Lin M, Cavnar MJ, Pandalai PK, et al
    Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.
    PLoS One. 2022;17:e0270832.
    PubMed     Abstract available

  83. DASGUPTA R, Jebasingh FK, Anoop S, Seenivasan S, et al
    Comprehensive evaluation of patterns of hypoglycemia unawareness (HUA) and glycemic variability (GV) in patients with fibrocalculous pancreatic diabetes (FCPD): A cross-sectional study from South India.
    PLoS One. 2022;17:e0270788.
    PubMed     Abstract available

  84. LI Y, Maedler K, Shu L, Haataja L, et al
    Correction: UCP-2 and UCP-3 Proteins Are Differentially Regulated in Pancreatic Beta-Cells.
    PLoS One. 2022;17:e0271783.
    PubMed     Abstract available

  85. SAITO D, Nakagawa Y, Sato T, Fukunaka A, et al
    Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic gamma cells.
    PLoS One. 2022;17:e0269958.
    PubMed     Abstract available

  86. KNOCHE SM, Brumfield GL, Goetz BT, Sliker BH, et al
    The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
    PLoS One. 2022;17:e0273518.
    PubMed     Abstract available

  87. Retraction: Boswellic Acid Suppresses Growth and Metastasis of Human Pancreatic Tumors in an Orthotopic Nude Mouse Model through Modulation of Multiple Targets.
    PLoS One. 2022;17:e0275582.

  88. LEMANSKA A, Price CA, Jeffreys N, Byford R, et al
    BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
    PLoS One. 2022;17:e0275369.
    PubMed     Abstract available

  89. SHEBANITS K, Andersson-Assarsson JC, Larsson I, Carlsson LMS, et al
    Correction: Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference.
    PLoS One. 2022;17:e0276288.
    PubMed     Abstract available

  90. AGAWA S, Futagami S, Yamawaki H, Tsushima R, et al
    Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.
    PLoS One. 2022;17:e0275341.
    PubMed     Abstract available

  91. BERKE G, Gede N, Szadai L, Ocskay K, et al
    Bicarbonate defective CFTR variants increase risk for chronic pancreatitis: A meta-analysis.
    PLoS One. 2022;17:e0276397.
    PubMed     Abstract available

  92. MIYAMOTO R, Takahashi A, Ogasawara A, Ogura T, et al
    Three-dimensional simulation of the pancreatic parenchyma, pancreatic duct and vascular arrangement in pancreatic surgery using a deep learning algorithm.
    PLoS One. 2022;17:e0276600.
    PubMed     Abstract available

  93. OJO OA, Grant S, Amanze JC, Oni AI, et al
    Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic beta-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes.
    PLoS One. 2022;17:e0276984.
    PubMed     Abstract available

  94. KIM YJ, Oh CM, Park SK, Jung JY, et al
    Fasting blood glucose and risk of incident pancreatic cancer.
    PLoS One. 2022;17:e0274195.
    PubMed     Abstract available

  95. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    PubMed     Abstract available

  96. ZWART ES, Jeleniewski S, Boyd LNC, Meijer LL, et al
    Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.
    PLoS One. 2022;17:e0278377.
    PubMed     Abstract available

  97. BENJAKUL N, Prakobphol N, Tangshewinsirikul C, Dulyaphat W, et al
    Notch signaling regulates vasculogenic mimicry and promotes cell morphogenesis and the epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    PLoS One. 2022;17:e0279001.
    PubMed     Abstract available

  98. ABDELGAWAD R, Rathod YD, Alshammari M, Kelly L, et al
    Loss of Slc12a2 specifically in pancreatic beta-cells drives metabolic syndrome in mice.
    PLoS One. 2022;17:e0279560.
    PubMed     Abstract available

  99. SEQUEIRA IR, Yip W, Lu LW, Jiang Y, et al
    Exploring the relationship between pancreatic fat and insulin secretion in overweight or obese women without type 2 diabetes mellitus: A preliminary investigation of the TOFI_Asia cohort.
    PLoS One. 2022;17:e0279085.
    PubMed     Abstract available

    January 2021
  100. BARLASS U, Deshmukh A, Beck T, Bishehsari F, et al
    Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
    PLoS One. 2021;16:e0244285.
    PubMed     Abstract available

  101. YOSHIOKA R, Imamura H, Ichida H, Gyoda Y, et al
    Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows.
    PLoS One. 2021;16:e0244915.
    PubMed     Abstract available

  102. YABE SG, Fukuda S, Nishida J, Takeda F, et al
    Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
    PLoS One. 2021;16:e0245204.
    PubMed     Abstract available

  103. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available

  104. XIE J, Peng Y, Chen X, Li Q, et al
    LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    PLoS One. 2021;16:e0245908.
    PubMed     Abstract available

  105. HOLLENBACH M, Sonnenberg S, Sommerer I, Lorenz J, et al
    Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.
    PLoS One. 2021;16:e0242706.
    PubMed     Abstract available

  106. SOGAWA K, Takano S, Ishige T, Yoshitomi H, et al
    Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.
    PLoS One. 2021;16:e0246002.
    PubMed     Abstract available

  107. MUTHULINGAM JA, Olesen SS, Hansen TM, Brock C, et al
    Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    PLoS One. 2021;16:e0247653.
    PubMed     Abstract available

  108. LI T, Zhao H, Zhou H, Geng T, et al
    LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    PLoS One. 2021;16:e0247817.
    PubMed     Abstract available

  109. ZHANG C, Huang L, Xiong J, Xie L, et al
    Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    PLoS One. 2021;16:e0247752.
    PubMed     Abstract available

  110. CAO H, Qiang L, Chen J, Johnson KM, et al
    Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
    PLoS One. 2021;16:e0248111.
    PubMed     Abstract available

  111. WEYHE D, Obonyo D, Uslar VN, Stricker I, et al
    Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    PLoS One. 2021;16:e0248633.
    PubMed     Abstract available

  112. CHENG YH, Chiang EI, Syu JN, Chao CY, et al
    Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
    PLoS One. 2021;16:e0247550.
    PubMed     Abstract available

  113. SUGAWARA T, Ban D, Nishino J, Watanabe S, et al
    Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    PLoS One. 2021;16:e0249885.
    PubMed     Abstract available

  114. ZHANG W, Sakoda H, Nakazato Y, Islam MN, et al
    Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells.
    PLoS One. 2021;16:e0250232.
    PubMed     Abstract available

  115. ZHONG R, Jiang X, Peng Y, Xu H, et al
    A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.
    PLoS One. 2021;16:e0249911.
    PubMed     Abstract available

  116. TARTAGLIONE S, Mancini P, Viggiani V, Chirletti P, et al
    PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
    PLoS One. 2021;16:e0251656.
    PubMed     Abstract available

  117. TIAN T, Yang Q, Zhang C, Li X, et al
    MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2021;16:e0249375.
    PubMed     Abstract available

  118. ANTWI K, Wiesner P, Merkle EM, Zech CJ, et al
    Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
    PLoS One. 2021;16:e0253078.
    PubMed     Abstract available

  119. KATO T, Ono H, Fujii M, Akahoshi K, et al
    Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
    PLoS One. 2021;16:e0252917.
    PubMed     Abstract available

  120. DHAYAT SA, Tamim ANJ, Jacob M, Ebeling G, et al
    Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
    PLoS One. 2021;16:e0252727.
    PubMed     Abstract available

  121. MALHOTRA A, Rachet B, Bonaventure A, Pereira SP, et al
    Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data.
    PLoS One. 2021;16:e0251876.
    PubMed     Abstract available

  122. RAJA A, Malik MFA, Haq F
    Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
    PLoS One. 2021;16:e0252344.
    PubMed     Abstract available

  123. PEISL S, Mellenthin C, Vignot L, Gonelle-Gispert C, et al
    Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
    PLoS One. 2021;16:e0252397.
    PubMed     Abstract available

  124. UDRISTOIU AL, Cazacu IM, Gruionu LG, Gruionu G, et al
    Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model.
    PLoS One. 2021;16:e0251701.
    PubMed     Abstract available

  125. ULLGREN H, Fransson P, Olofsson A, Segersvard R, et al
    Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
    PLoS One. 2021;16:e0254673.
    PubMed     Abstract available

  126. ITO G, Kawakami K, Aoyama T, Yokokawa T, et al
    Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
    PLoS One. 2021;16:e0254726.
    PubMed     Abstract available

  127. STREICHER SA, Lim U, Park SL, Li Y, et al
    Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study.
    PLoS One. 2021;16:e0249615.
    PubMed     Abstract available

  128. IMURA T, Inagaki A, Igarashi Y, Goto M, et al
    Optimization of dye solutions for detecting damaged pancreatic tissues during islet isolation procedures.
    PLoS One. 2021;16:e0255733.
    PubMed     Abstract available

  129. KAFITA D, Nkhoma P, Zulu M, Sinkala M, et al
    Proteogenomic analysis of pancreatic cancer subtypes.
    PLoS One. 2021;16:e0257084.
    PubMed     Abstract available

  130. BARKO PC, Williams DA
    Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency.
    PLoS One. 2021;16:e0257856.
    PubMed     Abstract available

  131. GAO Y, Wang M, Guo X, Hu J, et al
    Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    PLoS One. 2021;16:e0250539.
    PubMed     Abstract available

  132. WESTENFELDER C, Hu Z, Zhang P, Gooch A, et al
    Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
    PLoS One. 2021;16:e0259043.
    PubMed     Abstract available

  133. WAKIYA T, Ishido K, Kimura N, Nagase H, et al
    Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree.
    PLoS One. 2021;16:e0259682.
    PubMed     Abstract available

  134. MAEDA K, Kuriyama N, Nakagawa Y, Ito T, et al
    Optimal management of peripancreatic fluid collection with postoperative pancreatic fistula after distal pancreatectomy: Significance of computed tomography values for predicting fluid infection.
    PLoS One. 2021;16:e0259701.
    PubMed     Abstract available

  135. XU YF, Xu X, Bhandari K, Gin A, et al
    Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    PLoS One. 2021;16:e0259563.
    PubMed     Abstract available

  136. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed     Abstract available

  137. LI X, Yang Q, Ye H, Li S, et al
    Comparison of pancreatic fat content measured by different methods employing MR mDixon sequence.
    PLoS One. 2021;16:e0260001.
    PubMed     Abstract available

  138. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    PubMed     Abstract available

  139. CHERUBINI A, Rusconi F, Lazzari L
    Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.
    PLoS One. 2021;16:e0260902.
    PubMed     Abstract available

  140. WEEGH N, Zentrich E, Zechner D, Struve B, et al
    Voluntary wheel running behaviour as a tool to assess the severity in a mouse pancreatic cancer model.
    PLoS One. 2021;16:e0261662.
    PubMed     Abstract available

  141. WURTZEL JGT, Lazar S, Sikder S, Cai KQ, et al
    Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice.
    PLoS One. 2021;16:e0261633.
    PubMed     Abstract available

  142. PHILLIP V, Schwab M, Haf D, Algul H, et al
    Correction: Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center.
    PLoS One. 2021;16:e0261576.
    PubMed     Abstract available

    January 2020
  143. CHOI MH, Yoon SB, Song M, Lee IS, et al
    Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
    PLoS One. 2020;15:e0240318.
    PubMed     Abstract available

  144. NWEKE EE, Naicker P, Aron S, Stoychev S, et al
    SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    PLoS One. 2020;15:e0240453.
    PubMed     Abstract available

  145. YAMAMOTO S, Nagamine Y, Miyashita T, Ito S, et al
    Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
    PLoS One. 2020;15:e0240490.
    PubMed     Abstract available

  146. PAVLIKOVA N, Sramek J, Jelinek M, Halada P, et al
    Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach.
    PLoS One. 2020;15:e0229430.
    PubMed     Abstract available

  147. CEBALLOS GA, Hernandez LF, Paredes D, Betancourt LR, et al
    A machine learning approach to predict pancreatic islet grafts rejection versus tolerance.
    PLoS One. 2020;15:e0241925.
    PubMed     Abstract available

  148. Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0242146.
    PubMed     Abstract available

  149. HUNG WC, Lee DY, Chiang EI, Syu JN, et al
    Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    PLoS One. 2020;15:e0241186.
    PubMed     Abstract available

  150. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2020;15:e0242974.
    PubMed     Abstract available

  151. SHEIKH M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, et al
    Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    PLoS One. 2020;15:e0243511.
    PubMed     Abstract available

  152. ROH YH, Kang BK, Song SY, Lee CM, et al
    Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy.
    PLoS One. 2020;15:e0243515.
    PubMed     Abstract available

  153. WOCHNER R, Clauss D, Nattenmuller J, Tjaden C, et al
    Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
    PLoS One. 2020;15:e0242785.
    PubMed     Abstract available

  154. DOI N, Ino Y, Angata K, Shimada K, et al
    Clinicopathological significance of core 3 O-glycan synthetic enzyme, beta1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0242851.
    PubMed     Abstract available

  155. GASTEIGER S, Primavesi F, Werkl P, Dostal L, et al
    The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.
    PLoS One. 2020;15:e0243510.
    PubMed     Abstract available

  156. DUORUI N, Shi B, Zhang T, Chen C, et al
    The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
    PLoS One. 2020;15:e0243164.
    PubMed     Abstract available

  157. MAHARAJ AD, Evans SM, Zalcberg JR, Ioannou LJ, et al
    Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework.
    PLoS One. 2020;15:e0243312.
    PubMed     Abstract available

  158. LIN ZB, Song JY, Li AC, Chen C, et al
    The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    PLoS One. 2020;15:e0243170.
    PubMed     Abstract available

  159. RAJPUT SA, Mirza MR, Choudhary MI
    Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells.
    PLoS One. 2020;15:e0241349.
    PubMed     Abstract available

  160. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0244896.
    PubMed     Abstract available

  161. CHEN CY, Liang SH, Su YY, Chiang NJ, et al
    Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
    PLoS One. 2020;15:e0244487.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.